Apple Tree Partners logo

Apple Tree Partners

North America, New York, United States, New York

Description

Apple Tree Partners is a venture capital firm that invests in pharmaceuticals, biotech, medtech, and healthcare services.

Investor Profile

Apple Tree Partners has made 62 investments, with 1 in the past 12 months and 55% as lead.

Stage Focus

  • Series A (39%)
  • Series B (18%)
  • Seed (10%)
  • Series D (8%)
  • Series C (6%)
  • Series E (6%)
  • Series Unknown (6%)
  • Post Ipo Equity (5%)
  • Debt Financing (2%)

Country Focus

  • United States (92%)
  • Canada (6%)
  • United Kingdom (2%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Pharmaceutical
  • Biopharma
  • Medical Device
  • Life Science
  • Genetics
  • Oncology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Apple Tree Partners frequently co-invest with?

Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 11
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 4
Versant Ventures
North America, California, United States, Menlo Park
Co-Investments: 5
Baxalta Ventures
North America, Massachusetts, United States, Cambridge
Co-Investments: 4
SR One
North America, Massachusetts, United States, Cambridge
Co-Investments: 4
Rock Springs Capital
North America, Maryland, United States, Baltimore
Co-Investments: 4
Excel Venture Management
North America, Massachusetts, United States, Boston
Co-Investments: 4
Roche Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 4
Lilly Ventures
North America, Indiana, United States, Indianapolis
Co-Investments: 4
Partners Innovation Fund
North America, Massachusetts, United States, Boston
Co-Investments: 4

Which angels does Apple Tree Partners often collaborate with?

SH
North America, California, United States, Palo Alto
Shared Deals: 1

What are some of recent deals done by Apple Tree Partners?

Red Queen Therapeutics

Cambridge, Massachusetts, United States

Red Queen Therapeutics is a biotechnology company.

BiotechnologyMedical
Series AAug 6, 2024
Amount Raised: $55,000,000
Deep Apple Therapeutics

New York, New York, United States

Deep Apple Therapeutics is discovering new small-molecule therapeutics with unprecedented speed and exceptional acumen.

BiotechnologyTherapeutics
Series ADec 14, 2023
Amount Raised: $52,000,000
Ascidian Therapeutics

Boston, Massachusetts, United States

Ascidian Therapeutics is a biotechnology company that focuses on medical and clinical gene therapy.

BiotechnologyGeneticsMedicalTherapeutics
Series ANov 8, 2023
Amount Raised: $40,000,000
Aulos Bioscience

Cambridge, Massachusetts, United States

Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics.

BiotechnologyHealth CareLife ScienceMedicalOncologyTherapeutics
Series AAug 1, 2023
Amount Raised: $20,000,000
Initial Therapeutics

South San Francisco, California, United States

Initial Therapeutics is a developer of small-molecule medicines designed to prevent pathogenic protein synthesis.

BiotechnologyTherapeutics
Series AMay 1, 2023
Amount Raised: $75,000,000
Aethon Therapeutics

New York, New York, United States

Aethon Therapeutics treats cancer by combining immunotherapy and targeted treatment to increase its effectiveness.

BiotechnologyHealth CareProduct Research
Series AJan 9, 2023
Amount Raised: $30,000,000
Ascidian Therapeutics

Boston, Massachusetts, United States

Ascidian Therapeutics is a biotechnology company that focuses on medical and clinical gene therapy.

BiotechnologyGeneticsMedicalTherapeutics
Series AOct 12, 2022
Amount Raised: $50,000,000
Galvanize Therapeutics

San Carlos, California, United States

Galvanize is a biomedical platform company that provides therapeutic products and services to deliver healthcare solutions.

Health CareMedicalMedical DeviceTherapeutics
Series BSep 15, 2022
Amount Raised: $100,000,000
Adendra Therapeutics

London, England, United Kingdom

Adendra Therapeutics wants to use new insights into dendritic cell biology to develop a novel type of immunotherapy.

BiopharmaBiotechnologyGeneticsHealth Care
Series ADec 7, 2021
Amount Raised: $52,982,378
Marengo Therapeutics

Cambridge, Massachusetts, United States

Marengo Therapeutics is seeking professionals who are motivated to make a positive difference in patients’ lives.

Health Care
Series BNov 8, 2021
Amount Raised: $80,000,000